Search
IRIDEX Corp
IRIXAdd to Watchlist
1.130USD
-0.040-3.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
19.66MMarket Cap
LossP/E TTM
More Details of IRIDEX Corp Company
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
IRIDEX Corp Info
Ticker SymbolIRIX
Company nameIRIDEX Corp
IPO dateFeb 16, 1996
CEOMercer (Patrick)
Number of employees93
Security typeOrdinary Share
Fiscal year-endFeb 16
Address1212 Terra Bella Ave
CityMOUNTAIN VIEW
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94043
Phone16509404700
Websitehttps://www.iridex.com/
Ticker SymbolIRIX
IPO dateFeb 16, 1996
CEOMercer (Patrick)
Company Executives of IRIDEX Corp
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
162.07K
-2.46%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
110.78K
+6.57%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
Mr. Bassem Bouhabib
Mr. Bassem Bouhabib
Vice President - International Sales
Vice President - International Sales
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. William M. (Will) Moore, Jr.
Mr. William M. (Will) Moore, Jr.
Independent Director
Independent Director
402.00K
--
Mr. Patrick Mercer
Mr. Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
President, Chief Executive Officer, Chief Operating Officer, Director
162.07K
-2.46%
Mr. Romeo R. Dizon
Mr. Romeo R. Dizon
Chief Financial Officer
Chief Financial Officer
110.78K
+6.57%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
92.64K
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Yu Hao (Nick) Chen
Mr. Yu Hao (Nick) Chen
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of IRIDEX Corp?
The top five shareholders of IRIDEX Corp are: Mr. William M. (Will) Moore, Jr.
How many institutions hold shares of IRIDEX Corp (IRIX)?
As of 2026Q1, 52 institutions hold shares of IRIDEX Corp, with a combined market value of approximately 3.69M, accounting for 21.29% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 278304.00.
What is the biggest source of revenue for IRIDEX Corp?
In 2026Q1, the Retina business generated the highest revenue for IRIDEX Corp, amounting to 6.70M and accounting for 53.65% of total revenue.